Cart
sales@molnova.com
ent-16beta,17-dihydroxy-9(11)-kauren-19-oic acid
CAS No. 55483-24-4
ent-16beta,17-dihydroxy-9(11)-kauren-19-oic acid( —— )
Catalog No. M31919 CAS No. 55483-24-4
ent-16beta,17-dihydroxy-9(11)-kauren-19-oic acid is a natural product of Xanthium, Asteraceae. ent-16beta,17-dihydroxy-9(11)-kauren-19-oic acid can be used as a reference standard.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 630 | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
Biological Information
-
Product Nameent-16beta,17-dihydroxy-9(11)-kauren-19-oic acid
-
NoteResearch use only, not for human use.
-
Brief Descriptionent-16beta,17-dihydroxy-9(11)-kauren-19-oic acid is a natural product of Xanthium, Asteraceae. ent-16beta,17-dihydroxy-9(11)-kauren-19-oic acid can be used as a reference standard.
-
Descriptionent-16beta,17-dihydroxy-9(11)-kauren-19-oic acid is a natural product of Xanthium, Asteraceae. ent-16beta,17-dihydroxy-9(11)-kauren-19-oic acid can be used as a reference standard.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number55483-24-4
-
Formula Weight334.5
-
Molecular FormulaC20H30O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
FTO-IN-3
FTO-IN-3 is a FTO inhibitor that impair self-renewal in glioblastoma stem cells.
-
SMS1-IN-1
SMS1-IN-1 is a potent inhibitor of sphingomyelin synthase 1 (SMS1, IC50 = 2.1 μM), and can be used in the atherosclerosis studies.
-
CMF019
CMF019 is a potent agonist of the Apelin receptor (APJ) with G protein bias. CMF019 binds to APJ (pKis: 8.58, 8.49, and 8.71 for the human, rat, and mouse).
